MRI: Effective Tool For Determining Pathologic Stage Of Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: MRI / PET / Ultrasound;  Clinical Trials / Drug Trials
Article Date: 24 Apr 2009 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)


In patients with prostate cancer undergoing prostatectomy, MR imaging plays an important role in determining if the cancer is restricted to the prostate gland or if it has spread beyond the capsule, according to a study performed at the University of California, Los Angeles, Los Angeles, CA.

The study included a review of 119 patients who were referred for prostate MRI prior to prostatectomy. "Results showed that MRI correctly identified 87/92 (95%) of patients with T2 and 6/8 (75%) of patients with T3 disease (T2 means the disease is organ confined and T3 means the disease has locally spread beyond the prostate)," said Timothy McClure, MD, lead author of the study. Steven Raman, MD, worked with Dr. McClure on this study.

"Current techniques for prostate cancer diagnosis are inaccurate in differentiating men who need treatment from those who do not. In fact, recent studies have even questioned the role of PSA (prostate-specific antigen) screening in the general population, given the side effects of treatment. As such, there has been much interest in focal therapy in prostate cancer treatment; but this will require a more accurate diagnosis, especially the ability to detect high grade cancers. A new paradigm for prostate cancer diagnosis needs to be developed and our study suggests that MR imaging of the prostate may play a role," said Dr. McClure.

This study will be presented at the 2009 ARRS Annual Meeting in Boston, MA, on Tuesday, April 28.

About ARRS

The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Roentgen, who discovered the x-ray in 1895.

Source: American Roentgen Ray Society (ARRS)

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
American Roentgen Ray Society (ARRS). "MRI: Effective Tool For Determining Pathologic Stage Of Prostate Cancer." Medical News Today. MediLexicon, Intl., 24 Apr. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/147385.php>

APA
American Roentgen Ray Society (ARRS). (2009, April 24). "MRI: Effective Tool For Determining Pathologic Stage Of Prostate Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/147385.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »